Will 2022 Be Medtech's Biggest Year for M&A?
Will 2022 be the year of medtech M&A. EY’s John Babitt joins us to talk about acquisition trends and deal-making activity in the latest episode of Let’s Talk Medtech.
Omar Ford
January 27, 2022
1 Min Read
Image Courtesy of EY
Medtech M&A took off in 2021 and if there’s any indication to the recent earnings reports that came out, 2022 could be an even bigger year. John Babitt, a Life Science Partner with EY joins us for this episode of Let’s Talk Medtech for a candid conversation regarding M&A.
Babitt speaks on trends reported in EY’s Annual M&A Firepower Report. Click here for a transcript of the first 1,000 words of Let’s Talk Medtech’s conversation with John Babitt, and check below for the full episode.
About the Author
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like